Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 7—July 2010

Research

Zoonotic Transmission of Avian Influenza Virus (H5N1), Egypt, 2006–2009

Amr Kandeel, Serge Manoncourt, Eman Abd el Kareem, Abdel-Nasser Mohamed Ahmed, Samir El-Refaie, Hala Essmat, Jeffrey Tjaden, Cecilia C. de Mattos, Kenneth C. EarhartComments to Author , Anthony A. Marfin, and Nasr El-Sayed
Author affiliations: Ministry of Health, Cairo, Egypt (A. Kandeel, E.A. el Kareem, A.-N. M. Ahmed, S. El-Refaie, H. Essmat, N. El-Sayed); US Naval Medical Research Unit 3, Cairo (S. Manoncourt, H. Essmat, J. Tjaden, C.C. de Mattos, K.C. Earhart, A.A. Marfin); US Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A.A. Marfin)

Main Article

Table 4

CFRs for 63 persons infected with avian influenza virus (H5N1), Egypt, 2006–2009*

Characteristic Total no. No. died CFR, %
Sex†
F 40 21 52.5
M
23
3
13
Age group, y‡
0–4 23 0 0
5–14 11 2 18
15–49 27 20 74
>50 2 2 100
All ages
63
24
38
Days between illness onset and hospitalization§
0–2 32 4 12.5
3–4 12 4 33
5–6 9 8 89
>7
9
8
89
Days between illness onset and first oseltamivir dose¶
0–2 25 1 4
3–4 14 3 21
5–6 7 5 71
>7 12 11 92

*CFR, case-fatality rate.
†p = 0.0004, by χ2 test for CFR for female patients vs. that for male patients.
‡p<0.001, by χ2 test for patients <15 years of age vs. patients >15 years of age.
§p<0.001, by χ2 test for patients hospitalized <2 d after illness onset vs. patients hospitalized after 2 d.
¶p<0.001, by χ2 test for patients who received oseltamivir <2 d after illness onset vs. patients who received oseltamivir after 2 d.

Main Article

TOP